Hello,

 

Thank you very much for your inquiry. Your message has been forwarded to the appropriate decision makers within Gilead.

 

We are committed to doing everything we can to support the global health community in responding to the novel coronavirus (COVID-19) outbreak.

 

As you might imagine, we are receiving many inquiries every day related to our efforts to provide our antiviral expertise and resources to address the COVID-19 outbreak. As such, we appreciate your patience while we review your inquiry.

 

Best Regards,

Gilead Sciences

 

 

 

 

Dear Sir/Madam,

 

I would like to kindly address you from the Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia. Please, find the enclosed letter signed by the Minister – Ms. Ekaterine Tikaradze regarding the possibility of engagement in the study of Remdesivir for the treatment of the patients with severe acute respiratory syndrome of COVID-19.

 

We kindly ask you to assist us in obtaining the response as soon as possible to the request addressed to Dr. Daniel O'Day.

 

Thank you in advance for continued support and partnership.

 

Looking forward to hearing from you.

 

With best regards,

 

 

 

Maia Nikoleishvili MPA

 

Acting Head of International Relations and Protocol Division of Administration

Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia

Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia

Tel.: +995 32 2510034 (0803)

Cell phone: +995 577272713

E-mail: mnikoleishvili@moh.gov.ge